News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant (VRX) Used One Simple Strategy To Get Insurers To Pay For A $1,000 Drug With $100 Alternatives



11/10/2016 7:05:06 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
How do you convince someone to pay $1,000 for a drug when they can buy an identical alternative for $100?

Valeant Pharmaceuticals has one answer: Pay fat rebates to the people who decide whether your insurer covers the drug.

The drug in question here is Solodyn, an acne-treating antibiotic. Its sales had tumbled by 40% since it went off patent in 2011. Then Valeant struck a deal with a specialty pharmacy called Philidor and started to turn things around.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES